title: Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
authors.affiliation: Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil. Electronic address: 100alergia@gmail.com.
authors.forename: Luis Felipe
authors.initials: LF
authors.lastname: Ensina
authors.affiliation: Federal University of São Paulo, São Paulo, Brazil.
authors.forename: Alex Eustáquio
authors.initials: AE
authors.lastname: de Lacerda
authors.affiliation: Federal University of São Paulo, São Paulo, Brazil.
authors.forename: Ligia Maria de Oliveira
authors.initials: LM
authors.lastname: Machado
authors.affiliation: Federal University of São Paulo, São Paulo, Brazil; University of Santo Amaro, São Paulo, Brazil.
authors.forename: Inês
authors.initials: I
authors.lastname: Camelo-Nunes
authors.affiliation: Federal University of São Paulo, São Paulo, Brazil.
authors.forename: Dirceu
authors.initials: D
authors.lastname: Solé
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D000069444:Omalizumab / Q000627:therapeutic use*; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000069444:Omalizumab